Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-038056
Filing Date
2013-07-02
Accepted
2013-07-02 16:58:50
Documents
1
Period of Report
2013-07-01

Document Format Files

Seq Description Document Type Size
1 rrd385009.html 4  
1 rrd385009.xml 4 3274
  Complete submission text file 0001181431-13-038056.txt   4607
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
McMahon Gerald PhD (Reporting) CIK: 0001290747 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 13949491